Q2 EPS Forecast for Core Laboratories Decreased by Analyst

Core Laboratories Inc. (NYSE:CLB - Free Report) - Research analysts at Zacks Research cut their Q2 2025 earnings per share estimates for Core Laboratories in a research note issued on Wednesday, March 26th. Zacks Research analyst T. Saha now anticipates that the oil and gas company will earn $0.21 per share for the quarter, down from their prior estimate of $0.25. The consensus estimate for Core Laboratories' current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories' Q1 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.34 EPS and FY2027 earnings at $1.28 EPS.

Separately, Citigroup upgraded Core Laboratories from a "sell" rating to a "neutral" rating and upped their price target for the stock from $15.00 to $16.00 in a research report on Wednesday, March 12th. One analyst has rated the stock with a sell rating and four have assigned a hold rating to the company. Based on data from MarketBeat, Core Laboratories has a consensus rating of "Hold" and an average target price of $17.50.

Core Laboratories Stock Performance

Shares of NYSE:CLB traded up $0.10 during midday trading on Friday, hitting $15.09. The company had a trading volume of 118,115 shares, compared to its average volume of 371,777. The company has a market cap of $706.39 million, a price-to-earnings ratio of 22.86, a PEG ratio of 0.99 and a beta of 2.38. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71. The company has a fifty day moving average of $16.34 and a two-hundred day moving average of $18.10. Core Laboratories has a 12-month low of $12.95 and a 12-month high of $25.13.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%.

Institutional Investors Weigh In On Core Laboratories

Institutional investors and hedge funds have recently bought and sold shares of the business. Confluence Investment Management LLC grew its position in shares of Core Laboratories by 0.4% during the fourth quarter. Confluence Investment Management LLC now owns 136,359 shares of the oil and gas company's stock worth $2,360,000 after purchasing an additional 599 shares in the last quarter. Isthmus Partners LLC grew its stake in Core Laboratories by 5.6% during the fourth quarter. Isthmus Partners LLC now owns 11,219 shares of the oil and gas company's stock valued at $194,000 after acquiring an additional 599 shares in the last quarter. Tidal Investments LLC grew its stake in Core Laboratories by 1.7% during the third quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company's stock valued at $813,000 after acquiring an additional 716 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Core Laboratories by 3.7% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,723 shares of the oil and gas company's stock valued at $463,000 after acquiring an additional 960 shares during the last quarter. Finally, Smartleaf Asset Management LLC lifted its stake in Core Laboratories by 173.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company's stock worth $35,000 after purchasing an additional 1,293 shares in the last quarter. 97.81% of the stock is owned by institutional investors.

Core Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were paid a $0.01 dividend. The ex-dividend date was Monday, February 10th. This represents a $0.04 dividend on an annualized basis and a yield of 0.27%. Core Laboratories's payout ratio is presently 6.06%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.